Status:
RECRUITING
Meloxicam in Mohs Micrographic Surgery
Lead Sponsor:
University of Oklahoma
Conditions:
Postoperative Pain, Acute
Skin Cancer
Eligibility:
All Genders
18-110 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to explore alternative methods of postoperative pain control in Mohs micrographic surgery. The main aims are: * To provide more information to the Mohs surgery comm...
Detailed Description
Mohs micrographic surgery (MMS) is a microscope-guided tissue-sparing surgical procedure for the removal of certain skin cancers, in which 100% of the surgical margin is examined. It is the gold-stand...
Eligibility Criteria
Inclusion
- All adult patients who consents to the study and are undergoing Mohs micrographic surgery at the University of Oklahoma.
Exclusion
- Women who are pregnant, suspected to be pregnant, or planning to become pregnant during the study period will be excluded from participation.
- Chronic liver disease (chronic hepatitis, acute hepatitis, cirrhosis, NASH, NAFLD, alcoholic liver disease, hemochromatosis, Wilson's disease)
- Chronic kidney disease stage III or greater,
- Aspirin-sensitive asthma
- History of chronic NSAID use
- Patients vulnerable to drug interactions
- GI bleeds
- Peptic ulcers
- Non-English speakers
Key Trial Info
Start Date :
October 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 2 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07200544
Start Date
October 15 2025
End Date
August 2 2026
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73104